Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery

Sponsor
Arlyne Thung (Other)
Overall Status
Completed
CT.gov ID
NCT02033772
Collaborator
(none)
17
1
50.2
0.3

Study Details

Study Description

Brief Summary

The study is primarily a descriptive study examining the physiological, ventilatory, surgical, and recovery effects of patients ≤ 6 months of age who undergo thoracoscopic surgery and to determine the accuracy of transcutaneous CO2 (TC-CO2) and end-tidal CO2 (ET-CO2) during high frequency oscillatory ventilation (HFOV) and thoracoscopic procedures.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Thoracoscopic surgery

Study Design

Study Type:
Observational
Actual Enrollment :
17 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Oct 6, 2017
Actual Study Completion Date :
Oct 6, 2017

Arms and Interventions

Arm Intervention/Treatment
Thoracoscopic surgery

Infants undergoing thoracoscopic surgery.

Procedure: Thoracoscopic surgery

Outcome Measures

Primary Outcome Measures

  1. Change in transcutaneous CO2 [Duration of surgery, average of 3 hours.]

Secondary Outcome Measures

  1. Change in ET-CO2 [Duration of surgery, average of 3 hours.]

    End-tidal CO2

  2. Change in heart rate [Duration of surgery, average of 3 hours.]

  3. Change in blood pressure [Duration of surgery, average of 3 hours.]

    Non-invasive and invasive.

  4. Change in SpO2 [Duration of surgery, average of 3 hours.]

    Oxygen saturation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 6 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients presenting for thoracoscopic surgery

  • Patients aged ≤ 6 months of age

Exclusion Criteria:
  • Patients presenting for any procedure other than thoracoscopic surgery

  • Patients aged > 6 months of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nationwide Children's Hospital Columbus Ohio United States 43205

Sponsors and Collaborators

  • Arlyne Thung

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Arlyne Thung, Assistant Clinical Professor, Nationwide Children's Hospital
ClinicalTrials.gov Identifier:
NCT02033772
Other Study ID Numbers:
  • IRB12-00503
First Posted:
Jan 13, 2014
Last Update Posted:
Jan 12, 2018
Last Verified:
Jan 1, 2018

Study Results

No Results Posted as of Jan 12, 2018